Roivant Sciences ROIV EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from Roivant Sciences’s reported figures.
Based on trailing twelve months.
The official record: Roivant Sciences’s 10-Q, filed February 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Roivant Sciences's ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Roivant Sciences's EBITDA margin?
- Roivant Sciences (ROIV) reported EBITDA margin of -9,099.5% in Q4 2025.
- How has Roivant Sciences's EBITDA margin changed year-over-year?
- Roivant Sciences's EBITDA margin decreased by 296.3% year-over-year, from -2,296.4% to -9,099.5%.
- What is the long-term trend for Roivant Sciences's EBITDA margin?
- Over 2 years (2022 to 2024), Roivant Sciences's EBITDA margin has grown at a 11.9% compound annual growth rate (CAGR), from -2,720.3% to -3,404.9%.
- What does EBITDA margin mean?
- Operating cash profitability per sales dollar, before interest, taxes, and non-cash charges.
- How do you interpret EBITDA margin?
- Useful for comparing operating profitability across firms with different depreciation policies and leverage. High EBITDA margin alongside heavy capex can still mean weak free cash flow — pair it with FCF margin.
- How does EBITDA margin compare across companies?
- Widely used to compare capital-intensive businesses on a like-for-like basis. Less meaningful for banks and insurers.